Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 1/2 1

Status

Completed 6Recruiting 5Unknown 4Terminated 2Not yet recruiting 1

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Conditions

Breast Neoplasms 5004Neoplasms 4197Prostatic Neoplasms 2428Carcinoma, Non-Small-Cell Lung 2265Colorectal Neoplasms 2053Lung Neoplasms 1705Multiple Myeloma 1459Lymphoma 1405Leukemia, Myeloid, Acute 1382Neoplasm Metastasis 1374Melanoma 1270Pancreatic Neoplasms 1200Leukemia 1196Ovarian Neoplasms 1192Lymphoma, Non-Hodgkin 1132Precursor Cell Lymphoblastic Leukemia-Lymphoma 1091Head and Neck Neoplasms 1056Leukemia, Lymphocytic, Chronic, B-Cell 994Lymphoma, Follicular 897Colonic Neoplasms 895Brain Neoplasms 876Stomach Neoplasms 857Recurrence 853Carcinoma, Hepatocellular 846Glioblastoma 841Lymphoma, Large B-Cell, Diffuse 771Rectal Neoplasms 759Uterine Cervical Neoplasms 728Carcinoma, Renal Cell 705Hodgkin Disease 698

Interventions

Radiotherapy 1Nivolumab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Interventional × Advanced Tumors × Clear all
NCT03444714 2025-09-15

Phase I Study of RiMO-301 With Radiation in Advanced Tumors

Coordination Pharmaceuticals, Inc.

Phase 1 Completed
32 enrolled

Advanced Tumors

NCT05429008 2025-06-18

A Phase I Clinical Study of HMPL-A83 in Patients With Advanced Malignant Neoplasm

Hutchmed

Phase 1 Completed
40 enrolled

Advanced Tumors

NCT04151810 2024-08-27

Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors

Dragonboat Biopharmaceutical Company Limited

Phase 1 Completed
32 enrolled

Advanced Tumors

NCT04808453 2024-02-07

CPI-300

Coordination Pharmaceuticals, Inc.

Phase 1 Completed
17 enrolled

Advanced Tumors

NCT03781362 2022-07-20

Study of CPI-100 in Patients With Advanced Tumors

Coordination Pharmaceuticals, Inc.

Phase 1 Completed
36 enrolled

Advanced Tumors

NCT02419417 2022-06-16

BET

Bristol-Myers Squibb

Phase 1/2 Completed
83 enrolled 47 charts

Advanced Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡